Skip to main content
Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery 3/2023

14.02.2023 | Original Article

Management of Oral Sub Mucous Fibrosis Using Three Different Flaps: Superficial Temporal, Nasolabial Flap, Buccal Fat Pad Flap Along with Active Physiotherapy- A Comparative Study

verfasst von: Deepak Koul, Shilpa Arora, Amit Sangle, Tehseen Desai, Zahid Afzal F. Inamdar

Erschienen in: Indian Journal of Otolaryngology and Head & Neck Surgery | Ausgabe 3/2023

Einloggen, um Zugang zu erhalten

Abstract

To assess the efficacy of different flaps along with active physiotherapy for comprehensive management of OSMF. A total of 33 patients of oral submucous fibrosis were admitted and surgically treated. All patients were diagnosed with bilateral oral submucous fibrosis of buccal mucosa. All the patients had advanced oral sub mucous fibrosis with interincisal distance less than 20 mm. Eleven patients were treated with buccal pad of fat, eleven with nasolabial flap and eleven patients were treated with temporo-parietal fascia flap. Physiotherapy was started from the 5th postoperative day and the patients were followed regularly for one year to measure maximum interincisal distance. There was a significant corelation between post-operative mouth opening and regular physiotherapy, exercise and quitting of the habit irrespective of type of reconstruction flap used. On the basis of the result obtained from this study, significant improvement in mouth opening was seen in patients who performed aggressive physiotherapy irrespective of the flap used. Thus we conclude along with the surgical treatment, post-operative physiotherapy and cessation of habit are of equal importance for good prognosis in OSMF patients.
Literatur
1.
Zurück zum Zitat Pindborg JJ, Sirsat SM (1966) Oral submucous fibrosis. J Oral Surg 22:764CrossRef Pindborg JJ, Sirsat SM (1966) Oral submucous fibrosis. J Oral Surg 22:764CrossRef
3.
Zurück zum Zitat Gupta D, Sharma SC (1988) Oral submucous fibrosis- a new treatment regimen. J Oral Maxillofac Surg 46(10):830–833CrossRefPubMed Gupta D, Sharma SC (1988) Oral submucous fibrosis- a new treatment regimen. J Oral Maxillofac Surg 46(10):830–833CrossRefPubMed
4.
Zurück zum Zitat Paymaster JC (1956) Cancer of the buccal mucosa: a clinical study of 650 cases in Indian patients. Cancer 9(3):431–435CrossRefPubMed Paymaster JC (1956) Cancer of the buccal mucosa: a clinical study of 650 cases in Indian patients. Cancer 9(3):431–435CrossRefPubMed
5.
Zurück zum Zitat Canniff JP, Harvey W, Harris M (1986) Oral submucousfibrosis:its pathogenesis and management. Br Dent J 160(12):429–434CrossRefPubMed Canniff JP, Harvey W, Harris M (1986) Oral submucousfibrosis:its pathogenesis and management. Br Dent J 160(12):429–434CrossRefPubMed
6.
Zurück zum Zitat Pindborg JJ, Bhonsle RB, Murti PR et al (1980) Incidence and early forms of oral submucous fibrosis. J Oral Surg 50:40CrossRef Pindborg JJ, Bhonsle RB, Murti PR et al (1980) Incidence and early forms of oral submucous fibrosis. J Oral Surg 50:40CrossRef
7.
Zurück zum Zitat Mahar R, Lee AJ, Warnakulasuriyen KA, Lewis JA, Johnson NW (1994) Role of arecanut in the causation of oral sub mucous fibrosis: a case- control study in Pakistan. J Oral Path Med 23:65–69CrossRef Mahar R, Lee AJ, Warnakulasuriyen KA, Lewis JA, Johnson NW (1994) Role of arecanut in the causation of oral sub mucous fibrosis: a case- control study in Pakistan. J Oral Path Med 23:65–69CrossRef
8.
Zurück zum Zitat Angadi PV, Rao SS (2011) Areca nut in pathogenesis of oral submucous fibrosis:revisited. Oral Maxillofac Surg 15:1–9CrossRefPubMed Angadi PV, Rao SS (2011) Areca nut in pathogenesis of oral submucous fibrosis:revisited. Oral Maxillofac Surg 15:1–9CrossRefPubMed
9.
Zurück zum Zitat Lee CH, Ko YC, Huang HL, Chao YY, Tsai CC (2003) The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan. Br J Cancer 88:366–372CrossRefPubMedPubMedCentral Lee CH, Ko YC, Huang HL, Chao YY, Tsai CC (2003) The precancer risk of betel quid chewing, tobacco use and alcohol consumption in oral leukoplakia and oral submucous fibrosis in southern Taiwan. Br J Cancer 88:366–372CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat KhannaJ N, Andrade NN (1995) OSMF:a new concept in surgical management-report of 100 cases. IJOMS 24:433–439 KhannaJ N, Andrade NN (1995) OSMF:a new concept in surgical management-report of 100 cases. IJOMS 24:433–439
11.
Zurück zum Zitat Borle RM, Borle SR (1991) Management of oral submucousfibrosis: a conservative approach. J Oral Maxillofac Surg 49:788CrossRefPubMed Borle RM, Borle SR (1991) Management of oral submucousfibrosis: a conservative approach. J Oral Maxillofac Surg 49:788CrossRefPubMed
13.
Zurück zum Zitat Yeh CJ (1996) Application of the buccal fat pad to the surgical treatment of oral submucous fibrosis. Int J Oral Maxillofac Surg 25:130CrossRefPubMed Yeh CJ (1996) Application of the buccal fat pad to the surgical treatment of oral submucous fibrosis. Int J Oral Maxillofac Surg 25:130CrossRefPubMed
14.
Zurück zum Zitat Mehrotra D, Pradhan R, Gupta S (2009) Retrospective comparison of surgical treatment modalities in 100 patients with oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107:e1–e10CrossRefPubMed Mehrotra D, Pradhan R, Gupta S (2009) Retrospective comparison of surgical treatment modalities in 100 patients with oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107:e1–e10CrossRefPubMed
15.
Zurück zum Zitat Borle RM, Nimonkar PV, Rajan R (2009) Extended nasolabial flaps in the management of oral submucous fibrosis. Br J Oral Maxillofac Surg 47:382CrossRefPubMed Borle RM, Nimonkar PV, Rajan R (2009) Extended nasolabial flaps in the management of oral submucous fibrosis. Br J Oral Maxillofac Surg 47:382CrossRefPubMed
16.
Zurück zum Zitat Schmidt BL, Dierks EJ (2003) The nasolabial flap. Oral Maxillofac Surg Clin North Am 15(4):487–495CrossRefPubMed Schmidt BL, Dierks EJ (2003) The nasolabial flap. Oral Maxillofac Surg Clin North Am 15(4):487–495CrossRefPubMed
17.
Zurück zum Zitat Cheema SA (2003) Clinical experience with nasolabial flap: a versatile option. Annals 9(2):127–129 Cheema SA (2003) Clinical experience with nasolabial flap: a versatile option. Annals 9(2):127–129
18.
Zurück zum Zitat Tolhurst D, Carstens M, Greco R, Hurwitz D (1991) The surgical anatomy of the scalp. Plast Reconstr Surg 87(4):603–612CrossRefPubMed Tolhurst D, Carstens M, Greco R, Hurwitz D (1991) The surgical anatomy of the scalp. Plast Reconstr Surg 87(4):603–612CrossRefPubMed
19.
Zurück zum Zitat Tremolada C, Candiani P, Signorini M, Vigano M, Donati L (1994) The surgical anatomy of the subcutaneous fascial system of the scalp. Ann Plast Surg 32(1):8–14CrossRefPubMed Tremolada C, Candiani P, Signorini M, Vigano M, Donati L (1994) The surgical anatomy of the subcutaneous fascial system of the scalp. Ann Plast Surg 32(1):8–14CrossRefPubMed
20.
Zurück zum Zitat Cesteleyn L (2003) The temporoparietalgalea flap. Oral Maxillofac Surg Clin North Am 15(4):537–50CrossRefPubMed Cesteleyn L (2003) The temporoparietalgalea flap. Oral Maxillofac Surg Clin North Am 15(4):537–50CrossRefPubMed
21.
Zurück zum Zitat Mokal NJ, Raje RS, Ranade SV et al (2005) Release of oral submucousfibrosis and reconstruction using superficial temporal fascia flap and split skin graft—A new technique. Br J Plast Reconstr Surg 58:1055CrossRef Mokal NJ, Raje RS, Ranade SV et al (2005) Release of oral submucousfibrosis and reconstruction using superficial temporal fascia flap and split skin graft—A new technique. Br J Plast Reconstr Surg 58:1055CrossRef
24.
Zurück zum Zitat Lokesh U, Veena G, Jann A, Vivek GK, Shilpa MR (2014) Application of lasers for oral submucus fibrosis—an experimental study. Arch Crani Orofacial Sci 1(6):81–86 Lokesh U, Veena G, Jann A, Vivek GK, Shilpa MR (2014) Application of lasers for oral submucus fibrosis—an experimental study. Arch Crani Orofacial Sci 1(6):81–86
26.
Zurück zum Zitat Vijayakumar M, Priya D (2013) Physiotherapy for improving mouth opening & tongue protrution in patients with Oral Submucous Fibrosis (OSMF)—case series. Int J Pharm Sci Health Care 3(2):52–58 Vijayakumar M, Priya D (2013) Physiotherapy for improving mouth opening & tongue protrution in patients with Oral Submucous Fibrosis (OSMF)—case series. Int J Pharm Sci Health Care 3(2):52–58
27.
Zurück zum Zitat Alam S, Ali I, Giri KY et al (2013) Efficacy of aloe vera gel as an adjuvant treatment of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol 116(6):717–724CrossRefPubMed Alam S, Ali I, Giri KY et al (2013) Efficacy of aloe vera gel as an adjuvant treatment of oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol 116(6):717–724CrossRefPubMed
Metadaten
Titel
Management of Oral Sub Mucous Fibrosis Using Three Different Flaps: Superficial Temporal, Nasolabial Flap, Buccal Fat Pad Flap Along with Active Physiotherapy- A Comparative Study
verfasst von
Deepak Koul
Shilpa Arora
Amit Sangle
Tehseen Desai
Zahid Afzal F. Inamdar
Publikationsdatum
14.02.2023
Verlag
Springer India
Erschienen in
Indian Journal of Otolaryngology and Head & Neck Surgery / Ausgabe 3/2023
Print ISSN: 2231-3796
Elektronische ISSN: 0973-7707
DOI
https://doi.org/10.1007/s12070-022-03410-9

Weitere Artikel der Ausgabe 3/2023

Indian Journal of Otolaryngology and Head & Neck Surgery 3/2023 Zur Ausgabe

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.